← Back to Search

Artificial Intelligence

AI Genetic Counseling vs In-Person Genetic Counseling for Breast Cancer

N/A
Waitlist Available
Led By Zahraa Al-Hilli, MD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects diagnosed with Stage 0-3 breast cancer
Patients who do not satisfy current NCCN criteria for referral to a genetics counselor and genetics testing
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is studying the feasibility of using AI to help with genetic counseling for women with breast cancer.

Who is the study for?
This trial is for women recently diagnosed with Stage 0-3 breast cancer who don't meet the criteria for genetic testing as per NCCN guidelines. Participants must understand and be willing to sign a consent form and complete study questionnaires.
What is being tested?
The study compares traditional in-person genetic counseling with an AI-powered ChatBot program for patients. It aims to see if AI can help manage the increased demand for genetic counseling due to offering testing to all regardless of NCCN criteria.
What are the potential side effects?
Since this trial involves surveys, counseling, and genetic testing rather than medication or invasive procedures, there are no direct physical side effects associated with the interventions being tested.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My breast cancer is at stage 0 to 3.
Select...
I do not meet the criteria for genetic counseling according to NCCN guidelines.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Genetic screening method
Overall comprehension as assessed by BCGCKQ
Percent of participants who took up genetic testing after not meeting NCCN guidelines for genetic testing
Secondary study objectives
Frequencies of most common reasons for not pursuing genetic testing
Number of patients who decline genetic testing
Percentage of overall cohort with mutation
+1 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Artificial intelligence programExperimental Treatment4 Interventions
Will complete consult with the use of an artificial intelligence program Chatbot.
Group II: in-person genetic counselingActive Control4 Interventions
Will complete a traditional in-person genetic counseling. consult by meeting with a Genetics Counselor
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Genetic testing
2017
N/A
~5890

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
469 Previous Clinical Trials
33,435 Total Patients Enrolled
55 Trials studying Breast Cancer
5,073 Patients Enrolled for Breast Cancer
Zahraa Al-Hilli, MDPrincipal InvestigatorCleveland Clinic Taussig Cancer institute, Case Comprehensive Cancer Center
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Breast Cancer
100 Patients Enrolled for Breast Cancer

Media Library

Automated program (ChatBot) (Artificial Intelligence) Clinical Trial Eligibility Overview. Trial Name: NCT04354675 — N/A
Breast Cancer Research Study Groups: Artificial intelligence program, in-person genetic counseling
Breast Cancer Clinical Trial 2023: Automated program (ChatBot) Highlights & Side Effects. Trial Name: NCT04354675 — N/A
Automated program (ChatBot) (Artificial Intelligence) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04354675 — N/A
~8 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top